Nebraska Cancer Specialists — Omaha, Nebraska

Public research footprint of Nebraska Cancer Specialists, compiled from the ClinicalTrials.gov public registry.

394

Registered studies

242

Active

105

Recruiting now

104

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Lung Non-Squamous Non-Small Cell Carcinoma · Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT07492641 — BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nebraska Cancer Specialists?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.